metricas
covid
Buscar en
Medicina Clínica
Toda la web
Inicio Medicina Clínica Myositis and myocarditis with tremelimumab and durvalumab combination therapy fo...
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Myositis and myocarditis with tremelimumab and durvalumab combination therapy for hepatocellular carcinoma
Miositis y miocarditis tras terapia combinada de tremelimumab y durvalumab en el carcinoma hepatocelular
Thais Lizondo López
Corresponding author
tlizondo@clinic.cat

Corresponding author.
, Iria Carro Méndez, Esther Carcelero San Martín
Pharmacy Service, Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain
Read
2
Times
was read the article
0
Total PDF
2
Total HTML
Share statistics
Article information
ISSN: 00257753
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 2 0 2

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos